| 0 |
FACTOR XA ACTIVITY INCREASED |
1 |
0.0455 |
| 1 |
PRODUCT PREPARATION ISSUE |
184 |
0.0280 |
| 2 |
IMMATURE GRANULOCYTE PERCENTAGE INCREASED |
1 |
0.0164 |
| 3 |
PRODUCT CLOSURE ISSUE |
7 |
0.0126 |
| 4 |
INTRACARDIAC PRESSURE INCREASED |
1 |
0.0114 |
| 5 |
MEDICAL DEVICE SITE THROMBOSIS |
1 |
0.0097 |
| 6 |
SERRATIA SEPSIS |
1 |
0.0093 |
| 7 |
HYPERTROPHIC SCAR |
1 |
0.0092 |
| 8 |
FASCIOTOMY |
1 |
0.0089 |
| 9 |
TRAUMATIC SHOCK |
1 |
0.0087 |
| 10 |
ANTI FACTOR VIII ANTIBODY INCREASED |
1 |
0.0081 |
| 11 |
EPIDURAL HAEMORRHAGE |
1 |
0.0077 |
| 12 |
TISSUE INFILTRATION |
2 |
0.0068 |
| 13 |
HEPATIC ISCHAEMIA |
2 |
0.0064 |
| 14 |
PRODUCT RECONSTITUTION ISSUE |
2 |
0.0063 |
| 15 |
COSTOVERTEBRAL ANGLE TENDERNESS |
1 |
0.0061 |
| 16 |
FACTOR VIII DEFICIENCY |
1 |
0.0056 |
| 17 |
HEPATITIS B ANTIBODY POSITIVE |
1 |
0.0053 |
| 18 |
GENERAL PHYSICAL CONDITION DECREASED |
1 |
0.0053 |
| 19 |
INFUSION SITE NECROSIS |
1 |
0.0052 |
| 20 |
EXPOSURE TO UNSPECIFIED AGENT |
1 |
0.0051 |
| 21 |
HAEMOGLOBIN |
1 |
0.0050 |
| 22 |
NECROTISING SOFT TISSUE INFECTION |
1 |
0.0043 |
| 23 |
INFUSION SITE THROMBOSIS |
1 |
0.0037 |
| 24 |
HEPATITIS C ANTIBODY POSITIVE |
1 |
0.0037 |
| 25 |
RENAL ARTERY OCCLUSION |
1 |
0.0036 |
| 26 |
CATHETER SITE THROMBOSIS |
1 |
0.0036 |
| 27 |
IMMATURE GRANULOCYTE COUNT INCREASED |
1 |
0.0035 |
| 28 |
WRONG PRODUCT STORED |
1 |
0.0035 |
| 29 |
MEDICAL DEVICE SITE HAEMORRHAGE |
1 |
0.0035 |
| 30 |
INFUSION SITE EXTRAVASATION |
21 |
0.0034 |
| 31 |
RENAL ARTERY THROMBOSIS |
1 |
0.0032 |
| 32 |
ADMINISTRATION SITE SWELLING |
1 |
0.0031 |
| 33 |
PACKAGING DESIGN ISSUE |
1 |
0.0030 |
| 34 |
CEREBRAL AMYLOID ANGIOPATHY |
1 |
0.0030 |
| 35 |
ADMINISTRATION SITE EXTRAVASATION |
3 |
0.0030 |
| 36 |
PROTHROMBIN LEVEL INCREASED |
1 |
0.0029 |
| 37 |
ADMINISTRATION SITE BRUISE |
1 |
0.0029 |
| 38 |
MONOCYTE PERCENTAGE INCREASED |
2 |
0.0028 |
| 39 |
PRODUCT COMPOUNDING QUALITY ISSUE |
1 |
0.0027 |
| 40 |
EXTRAVASATION |
11 |
0.0027 |
| 41 |
BRAIN COMPRESSION |
1 |
0.0025 |
| 42 |
CRANIOTOMY |
1 |
0.0024 |
| 43 |
RED BLOOD CELL TRANSFUSION |
1 |
0.0024 |
| 44 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
3 |
0.0024 |
| 45 |
DEVICE ISSUE |
211 |
0.0024 |
| 46 |
PELVIC HAEMATOMA |
1 |
0.0023 |
| 47 |
SPLENIC HAEMORRHAGE |
1 |
0.0020 |
| 48 |
PROCEDURAL SITE REACTION |
1 |
0.0019 |
| 49 |
INFUSION SITE VESICLES |
1 |
0.0019 |
| 50 |
DEVICE CONNECTION ISSUE |
4 |
0.0019 |
| 51 |
NEUTROPHIL PERCENTAGE DECREASED |
1 |
0.0019 |
| 52 |
HAEMORRHAGIC INFARCTION |
1 |
0.0018 |
| 53 |
HAEMORRHAGIC OVARIAN CYST |
1 |
0.0017 |
| 54 |
DOSE CALCULATION ERROR |
1 |
0.0017 |
| 55 |
PNEUMONIA NECROTISING |
1 |
0.0015 |
| 56 |
EMBOLIC CEREBRAL INFARCTION |
1 |
0.0015 |
| 57 |
SILENT MYOCARDIAL INFARCTION |
1 |
0.0015 |
| 58 |
ABSCESS NECK |
1 |
0.0015 |
| 59 |
BRAIN CANCER METASTATIC |
1 |
0.0014 |
| 60 |
INFUSION SITE INFLAMMATION |
1 |
0.0014 |
| 61 |
THROMBOTIC STROKE |
1 |
0.0014 |
| 62 |
NO ADVERSE EVENT |
237 |
0.0013 |
| 63 |
PULMONARY ARTERY THROMBOSIS |
1 |
0.0013 |
| 64 |
COAGULATION TEST ABNORMAL |
1 |
0.0013 |
| 65 |
CRITICAL ILLNESS |
1 |
0.0013 |
| 66 |
METAPNEUMOVIRUS INFECTION |
1 |
0.0013 |
| 67 |
AORTIC DISORDER |
1 |
0.0013 |
| 68 |
PRODUCT LABEL CONFUSION |
7 |
0.0012 |
| 69 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
2 |
0.0012 |
| 70 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 71 |
CEREBELLAR INFARCTION |
2 |
0.0012 |
| 72 |
INFUSION SITE DISCOLOURATION |
1 |
0.0011 |
| 73 |
EMBOLIC STROKE |
4 |
0.0011 |
| 74 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
1 |
0.0011 |
| 75 |
ANAEMIA OF CHRONIC DISEASE |
1 |
0.0011 |
| 76 |
PRODUCT OUTER PACKAGING ISSUE |
1 |
0.0011 |
| 77 |
INTESTINAL INFARCTION |
1 |
0.0011 |
| 78 |
MEAN CELL HAEMOGLOBIN DECREASED |
2 |
0.0011 |
| 79 |
PRODUCT APPEARANCE CONFUSION |
1 |
0.0011 |
| 80 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 81 |
WRONG SCHEDULE |
1 |
0.0010 |
| 82 |
ACQUIRED HAEMOPHILIA |
1 |
0.0010 |
| 83 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 84 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
1 |
0.0009 |
| 85 |
CEREBRAL ARTERY OCCLUSION |
1 |
0.0009 |
| 86 |
INFUSION SITE MASS |
1 |
0.0009 |
| 87 |
PRODUCT SELECTION ERROR |
1 |
0.0009 |
| 88 |
CEREBRAL HAEMATOMA |
3 |
0.0009 |
| 89 |
SUBCLAVIAN VEIN THROMBOSIS |
1 |
0.0009 |
| 90 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 91 |
PUPILS UNEQUAL |
1 |
0.0009 |
| 92 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 93 |
EMBOLISM |
7 |
0.0008 |
| 94 |
PHYSICAL PRODUCT LABEL ISSUE |
1 |
0.0008 |
| 95 |
PRODUCT PACKAGING CONFUSION |
2 |
0.0008 |
| 96 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 97 |
INFUSION SITE SWELLING |
5 |
0.0008 |
| 98 |
CARDIAC VENTRICULAR THROMBOSIS |
1 |
0.0008 |
| 99 |
INTERCEPTED PRODUCT SELECTION ERROR |
1 |
0.0008 |
| 100 |
COMPARTMENT SYNDROME |
2 |
0.0008 |
| 101 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
1 |
0.0008 |
| 102 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 103 |
INTESTINAL MASS |
1 |
0.0007 |
| 104 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 105 |
INFUSION SITE RASH |
1 |
0.0007 |
| 106 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 107 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 108 |
GASTROINTESTINAL NECROSIS |
2 |
0.0007 |
| 109 |
BRAIN HERNIATION |
2 |
0.0007 |
| 110 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
2 |
0.0007 |
| 111 |
HAEMORRHAGIC TRANSFORMATION STROKE |
1 |
0.0007 |
| 112 |
THROMBOPHLEBITIS SUPERFICIAL |
2 |
0.0007 |
| 113 |
EMERGENCY CARE |
2 |
0.0007 |
| 114 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0007 |
| 115 |
INHIBITORY DRUG INTERACTION |
1 |
0.0006 |
| 116 |
SPLENIC RUPTURE |
1 |
0.0006 |
| 117 |
VENA CAVA THROMBOSIS |
1 |
0.0006 |
| 118 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
2 |
0.0006 |
| 119 |
PUPIL FIXED |
1 |
0.0006 |
| 120 |
SPLENIC INFARCTION |
1 |
0.0006 |
| 121 |
CEREBRAL INFARCTION |
14 |
0.0006 |
| 122 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 123 |
INTESTINAL ISCHAEMIA |
3 |
0.0005 |
| 124 |
BLOOD THYROID STIMULATING HORMONE ABNORMAL |
1 |
0.0005 |
| 125 |
DEVICE PHYSICAL PROPERTY ISSUE |
4 |
0.0005 |
| 126 |
SHOCK HAEMORRHAGIC |
4 |
0.0005 |
| 127 |
INJECTION SITE EXTRAVASATION |
6 |
0.0005 |
| 128 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 129 |
DEVICE LEAKAGE |
21 |
0.0005 |
| 130 |
ATRIAL THROMBOSIS |
1 |
0.0005 |
| 131 |
INTERNATIONAL NORMALISED RATIO FLUCTUATION |
1 |
0.0005 |
| 132 |
RED CELL DISTRIBUTION WIDTH INCREASED |
2 |
0.0005 |
| 133 |
PULSELESS ELECTRICAL ACTIVITY |
2 |
0.0005 |
| 134 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 135 |
VASCULAR OCCLUSION |
1 |
0.0005 |
| 136 |
HAEMORRHAGE INTRACRANIAL |
7 |
0.0005 |
| 137 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 138 |
INTERNATIONAL NORMALISED RATIO INCREASED |
13 |
0.0005 |
| 139 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 140 |
ISCHAEMIA |
2 |
0.0004 |
| 141 |
SUBDURAL HAEMATOMA |
6 |
0.0004 |
| 142 |
RETROPERITONEAL HAEMORRHAGE |
1 |
0.0004 |
| 143 |
INTRAVENTRICULAR HAEMORRHAGE |
1 |
0.0004 |
| 144 |
SYSTEMIC CANDIDA |
1 |
0.0004 |
| 145 |
PRODUCT SOLUBILITY ABNORMAL |
2 |
0.0004 |
| 146 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 147 |
CEREBRAL ISCHAEMIA |
2 |
0.0004 |
| 148 |
SUBDURAL HAEMORRHAGE |
1 |
0.0004 |
| 149 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 150 |
PRODUCT LEAKAGE |
2 |
0.0004 |
| 151 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 152 |
WRONG PATIENT RECEIVED PRODUCT |
1 |
0.0003 |
| 153 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 154 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 155 |
INTRACARDIAC THROMBUS |
1 |
0.0003 |
| 156 |
BRAIN DEATH |
1 |
0.0003 |
| 157 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 158 |
DEEP VEIN THROMBOSIS |
20 |
0.0003 |
| 159 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
1 |
0.0003 |
| 160 |
COAGULOPATHY |
5 |
0.0003 |
| 161 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 162 |
SUBARACHNOID HAEMORRHAGE |
3 |
0.0003 |
| 163 |
ECCHYMOSIS |
2 |
0.0003 |
| 164 |
DEVICE DEFECTIVE |
5 |
0.0003 |
| 165 |
DISSEMINATED INTRAVASCULAR COAGULATION |
4 |
0.0003 |
| 166 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 167 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 168 |
ISCHAEMIC STROKE |
5 |
0.0003 |
| 169 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 170 |
VENTRICULAR ARRHYTHMIA |
1 |
0.0003 |
| 171 |
ACUTE MYOCARDIAL INFARCTION |
8 |
0.0003 |
| 172 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 173 |
HAEMODYNAMIC INSTABILITY |
2 |
0.0003 |
| 174 |
PROCEDURAL HAEMORRHAGE |
1 |
0.0003 |
| 175 |
CEREBRAL HAEMORRHAGE |
9 |
0.0003 |
| 176 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 177 |
HEMIPLEGIA |
2 |
0.0002 |
| 178 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 179 |
DEVICE OPERATIONAL ISSUE |
1 |
0.0002 |
| 180 |
PYELONEPHRITIS |
2 |
0.0002 |
| 181 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 182 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 183 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 184 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 185 |
PULSE ABSENT |
1 |
0.0002 |
| 186 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 187 |
PANCREATIC DISORDER |
1 |
0.0002 |
| 188 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
1 |
0.0002 |
| 189 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 190 |
ENDOCARDITIS |
1 |
0.0002 |
| 191 |
SKIN NECROSIS |
1 |
0.0002 |
| 192 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 193 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 194 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 195 |
INTERNAL HAEMORRHAGE |
2 |
0.0002 |
| 196 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 197 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 198 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 199 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 200 |
CHOLANGITIS |
1 |
0.0002 |
| 201 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 202 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 203 |
UNRESPONSIVE TO STIMULI |
4 |
0.0002 |
| 204 |
MENINGITIS |
1 |
0.0001 |
| 205 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 206 |
PULMONARY EMBOLISM |
14 |
0.0001 |
| 207 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 208 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 209 |
THROMBOSIS |
11 |
0.0001 |
| 210 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 211 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 212 |
HAEMORRHAGE |
14 |
0.0001 |
| 213 |
APHASIA |
4 |
0.0001 |
| 214 |
DEVICE FAILURE |
2 |
0.0001 |
| 215 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 216 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 217 |
SENSORY LOSS |
1 |
0.0001 |
| 218 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 219 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0001 |
| 220 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 221 |
HAEMATURIA |
4 |
0.0001 |
| 222 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 223 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 224 |
CARDIAC ARREST |
9 |
0.0001 |
| 225 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 226 |
DRUG PRESCRIBING ERROR |
2 |
0.0001 |
| 227 |
ATELECTASIS |
1 |
0.0001 |
| 228 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 229 |
BRAIN INJURY |
1 |
0.0001 |
| 230 |
INJURY ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 231 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 232 |
PERITONITIS |
2 |
0.0001 |
| 233 |
PETECHIAE |
1 |
0.0001 |
| 234 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 235 |
SCRATCH |
1 |
0.0001 |
| 236 |
SUDDEN DEATH |
1 |
0.0001 |
| 237 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 238 |
SKIN LACERATION |
1 |
0.0001 |
| 239 |
SEPTIC SHOCK |
4 |
0.0001 |
| 240 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 241 |
HEPATITIS C |
1 |
0.0001 |
| 242 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 243 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 244 |
BRAIN OEDEMA |
1 |
0.0001 |
| 245 |
MYDRIASIS |
1 |
0.0001 |
| 246 |
GENITAL HAEMORRHAGE |
1 |
0.0001 |
| 247 |
HAEMATOMA |
2 |
0.0001 |
| 248 |
DEVICE BREAKAGE |
3 |
0.0001 |
| 249 |
LIMB INJURY |
2 |
0.0001 |
| 250 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 251 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 252 |
DIVERTICULITIS |
2 |
0.0001 |
| 253 |
GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0001 |
| 254 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 255 |
DEVICE MALFUNCTION |
5 |
0.0001 |
| 256 |
CEREBROVASCULAR ACCIDENT |
12 |
0.0001 |
| 257 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 258 |
BRONCHOSPASM |
1 |
0.0001 |
| 259 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 260 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 261 |
FLUID OVERLOAD |
1 |
0.0001 |
| 262 |
PULMONARY MASS |
1 |
0.0001 |
| 263 |
HEPATIC FAILURE |
2 |
0.0001 |
| 264 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 265 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 266 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 267 |
HYPOTENSION |
13 |
0.0001 |
| 268 |
ULCER |
1 |
0.0001 |
| 269 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 270 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 271 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 272 |
CANDIDA INFECTION |
1 |
0.0001 |
| 273 |
HEMIPARESIS |
1 |
0.0001 |
| 274 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 275 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 276 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 277 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 278 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 279 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 280 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 281 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 282 |
ACCIDENTAL EXPOSURE TO PRODUCT |
5 |
0.0000 |
| 283 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 284 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 285 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 286 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 287 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 288 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 289 |
MELAENA |
1 |
0.0000 |
| 290 |
ANGIOEDEMA |
2 |
0.0000 |
| 291 |
SHOCK |
1 |
0.0000 |
| 292 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 293 |
LIVER INJURY |
1 |
0.0000 |
| 294 |
HAEMATEMESIS |
1 |
0.0000 |
| 295 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 296 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 297 |
OEDEMA |
2 |
0.0000 |
| 298 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 299 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 300 |
MEDICATION ERROR |
2 |
0.0000 |
| 301 |
SEPSIS |
4 |
0.0000 |
| 302 |
HAEMOPTYSIS |
1 |
0.0000 |
| 303 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 304 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 305 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 306 |
NEEDLE ISSUE |
1 |
0.0000 |
| 307 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 308 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 309 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 310 |
ACUTE KIDNEY INJURY |
5 |
0.0000 |
| 311 |
PERIPHERAL SWELLING |
5 |
0.0000 |
| 312 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 313 |
NIGHT SWEATS |
1 |
0.0000 |
| 314 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 315 |
FUNGAL INFECTION |
1 |
0.0000 |
| 316 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 317 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 318 |
BURNING SENSATION |
2 |
0.0000 |
| 319 |
HYPOXIA |
1 |
0.0000 |
| 320 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 321 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 322 |
UNDERDOSE |
2 |
0.0000 |
| 323 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 324 |
INJECTION SITE MASS |
1 |
0.0000 |
| 325 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 326 |
DYSARTHRIA |
1 |
0.0000 |
| 327 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 328 |
ANAEMIA |
5 |
0.0000 |
| 329 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 330 |
DISORIENTATION |
1 |
0.0000 |
| 331 |
CARDIAC FAILURE |
2 |
0.0000 |
| 332 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 333 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 334 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 335 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 336 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 337 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 338 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 339 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 340 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 341 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 342 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 343 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 344 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 345 |
SWELLING |
2 |
0.0000 |
| 346 |
COMA |
1 |
0.0000 |
| 347 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 348 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 349 |
HYPOAESTHESIA |
3 |
0.0000 |
| 350 |
CELLULITIS |
1 |
0.0000 |
| 351 |
FLUSHING |
2 |
0.0000 |
| 352 |
SPEECH DISORDER |
1 |
0.0000 |
| 353 |
DRUG INTERACTION |
3 |
0.0000 |
| 354 |
BRADYCARDIA |
1 |
0.0000 |
| 355 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 356 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 357 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 358 |
EYE PAIN |
1 |
0.0000 |
| 359 |
EYE IRRITATION |
1 |
0.0000 |
| 360 |
CHILLS |
2 |
0.0000 |
| 361 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 362 |
FEELING HOT |
1 |
0.0000 |
| 363 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 364 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 365 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 366 |
FALL |
5 |
0.0000 |
| 367 |
OFF LABEL USE |
13 |
0.0000 |
| 368 |
NEUTROPENIA |
2 |
0.0000 |
| 369 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 370 |
DRUG INEFFECTIVE |
19 |
0.0000 |
| 371 |
OVERDOSE |
3 |
0.0000 |
| 372 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 373 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 374 |
HOSPITALISATION |
2 |
0.0000 |
| 375 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 376 |
DRUG ABUSE |
1 |
0.0000 |
| 377 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 378 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 379 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 380 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 381 |
TACHYCARDIA |
1 |
0.0000 |
| 382 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 383 |
CHEST PAIN |
2 |
0.0000 |
| 384 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 385 |
SYNCOPE |
1 |
0.0000 |
| 386 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 387 |
WEIGHT INCREASED |
2 |
0.0000 |
| 388 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 389 |
PALPITATIONS |
1 |
0.0000 |
| 390 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 391 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 392 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 393 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 394 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 395 |
RENAL FAILURE |
1 |
0.0000 |
| 396 |
DYSPNOEA |
4 |
0.0000 |
| 397 |
ANXIETY |
2 |
0.0000 |
| 398 |
RASH |
3 |
0.0000 |
| 399 |
HEADACHE |
4 |
0.0000 |
| 400 |
PARAESTHESIA |
1 |
0.0000 |
| 401 |
PNEUMONIA |
2 |
0.0000 |
| 402 |
TREMOR |
1 |
0.0000 |
| 403 |
PYREXIA |
2 |
0.0000 |
| 404 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 405 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 406 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 407 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 408 |
PAIN |
3 |
0.0000 |
| 409 |
ERYTHEMA |
1 |
0.0000 |
| 410 |
DIZZINESS |
2 |
0.0000 |
| 411 |
DEATH |
3 |
0.0000 |
| 412 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 413 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 414 |
ASTHENIA |
1 |
0.0000 |
| 415 |
FATIGUE |
1 |
0.0000 |